Oppenheimer Asset Management Inc. Charles River Laboratories International, Inc. Transaction History

Oppenheimer Asset Management Inc.

$6.65 Billion
Q1 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 43,314 shares of CRL stock, worth $8.73 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

43,314

Previous 44,348 2.33%

Holding current value

$8.73 Million

Previous $10.5 Million 11.94%

% of portfolio

0.18%

Previous 0.15%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$203.52 - $273.43 $210,439 - $282,726	-1,034 Reduced 2.33%	43,314 $11.7 Million
Q4 2023 Feb 13, 2024	SELL	$164.52 - $238.84 $607,078 - $881,319	-3,690 Reduced 7.68%	44,348 $10.5 Million
Q3 2023 Nov 07, 2023	SELL	$194.44 - $217.61 $146,218 - $163,642	-752 Reduced 1.54%	48,038 $9.41 Million
Q2 2023 Aug 02, 2023	BUY	$183.71 - $210.25 $348,314 - $398,634	1,896 Added 4.04%	48,790 $10.3 Million
Q1 2023 May 10, 2023	BUY	$191.89 - $259.92 $967,317 - $1.31 Million	5,041 Added 12.04%	46,894 $9.46 Million

Q4 2022 Feb 06, 2023	SELL	$197.11 - $250.07 $45,138 - $57,266	-229 Reduced 0.54%	41,853 $9.12 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $1.18 Million - $1.62 Million	6,447 Added 18.09%	42,082 $8.28 Million
Q2 2022 Aug 08, 2022	SELL	$204.13 - $302.4 $78,181 - $115,819	-383 Reduced 1.06%	35,635 $7.63 Million
Q1 2022 May 12, 2022	BUY	$255.51 - $362.11 $2.14 Million - $3.03 Million	8,367 Added 30.26%	36,018 $10.2 Million
Q4 2021 Feb 02, 2022	BUY	$351.38 - $448.68 $487,012 - $621,870	1,386 Added 5.28%	27,651 $10.4 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $781,798 - $961,513	-2,098 Reduced 7.4%	26,265 $10.8 Million
Q2 2021 Aug 03, 2021	BUY	$294.17 - $371.65 $166,206 - $209,982	565 Added 2.03%	28,363 $10.5 Million
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $2.79 Million - $3.35 Million	11,190 Added 67.38%	27,798 $8.06 Million
Q4 2020 Feb 11, 2021	SELL	$222.0 - $252.62 $105,450 - $119,994	-475 Reduced 2.78%	16,608 $4.15 Million
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $650,274 - $838,770	-3,704 Reduced 17.82%	17,083 $3.87 Million
Q2 2020 Aug 11, 2020	BUY	$118.84 - $189.72 $243,265 - $388,356	2,047 Added 10.92%	20,787 $3.62 Million
Q1 2020 May 08, 2020	SELL	$98.9 - $178.34 $6,032 - $10,878	-61 Reduced 0.32%	18,740 $2.37 Million
Q4 2019 Feb 07, 2020	BUY	$126.05 - $152.76 $34,537 - $41,856	274 Added 1.48%	18,801 $2.87 Million
Q3 2019 Oct 31, 2019	SELL	$125.07 - $143.67 $1,000 - $1,149	-8 Reduced 0.04%	18,527 $2.45 Million
Q2 2019 Aug 09, 2019	BUY	$123.4 - $148.55 $150,301 - $180,933	1,218 Added 7.03%	18,535 $2.63 Million
Q1 2019 Apr 24, 2019	SELL	$104.82 - $146.73 $41,508 - $58,105	-396 Reduced 2.24%	17,317 $2.52 Million
Q4 2018 Jan 30, 2019	BUY	$105.09 - $137.23 $945 - $1,235	9 Added 0.05%	17,713 $2.01 Million
Q3 2018 Oct 26, 2018	SELL	$112.11 - $134.54 $21,861 - $26,235	-195 Reduced 1.09%	17,704 $2.38 Million
Q2 2018 Aug 10, 2018	SELL	$102.37 - $117.25 $307,314 - $351,984	-3,002 Reduced 14.36%	17,899 $2.01 Million
Q1 2018 May 09, 2018	BUY	$98.19 - $115.2 $170,948 - $200,563	1,741 Added 9.09%	20,901 $2.23 Million
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $1.85 Million - $2.09 Million	19,160	19,160 $2.07 Million

Others Institutions Holding CRL

# of Institutions

728

Shares Held

51.3M

Call Options Held

183K

Put Options Held

346K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Charles River Laboratories International, Inc. Transaction History